Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024

TWST 10.24.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-18
Name of Upcoming Event:Twist Bioscience Conference Call
Full Press ReleaseSEC FilingsOur TWST Tweets

About Gravity Analytica

Recent News

  • 02.03.2025 - Fiscal 2025 First Quarter Financial Results Conference Call
  • 01.22.2025 - Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025
  • 01.14.2025 - 43rd Annual J.P. Morgan Healthcare Conference

Recent Filings

  • 01.14.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.10.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 01.10.2025 - 144 Report of proposed sale of securities

Press Release Details

Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024

Oct 24, 2024
PDF Version

Company to host conference call at8:00 AM ET

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct. 24, 2024--Twist Bioscience Corporation(NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 fourth quarter and full year endedSeptember 30, 2024, before the opening of the market onNovember 18, 2024. The company plans to hold a conference call and live audio webcast for analysts and investors at8:00 a.m. Eastern Timeto discuss its financial results and provide an update on the company’s business. The press release with the financial results will be accessible from the company’s website prior to the conference call through the Investor Relations section under the “Company” tab atwww.twistbioscience.com.

The conference call will be webcast live through the Investor Relations section under the “Company” tab atwww.twistbioscience.com. Those parties interested in participating via telephone must register on the Company’s Investor Relations website or by clickinghere. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks.

AboutTwist Bioscience Corporation

Twist Bioscienceis a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us onLinkedIn|X|YouTube|Instagram

View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241024652806/en/

For Investors:Angela BittingSVP, Corporate Affairs925-202-6211abitting@twistbioscience.com

For Media:Amanda HoulihanCommunications Manager774-265-5334ahoulihan@twistbioscience.com

Source:Twist Bioscience Corporation

  • Print Page
  • Email Page
  • Email Alerts
  • RSS Feeds
Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com